https://healthpolicy-watch.news/tb-vaccine-550m-boost-for-phase-3-trial/
0
0
TB Vaccine Candidate Receives $550M Boost For Phase 3 Trial - Health Policy Watch
6/29/23 at 2:37pm
Organization
Healthpolicy-watch.news
Author
https://www.facebook.com/HealthPolicyWatch
Details
38 words
Summarize
Infectious Diseases Public Health Public Safety Health Medical Procedures M Boost For Phase 3 Trial - Health Policy Watch A tuberculosis Tuberculosis efficacy rates Bill and Melinda Gates Foundation
A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and
Create an account or login to join the discussion